Doing More with Less: Capturing Adequate Cancer Family History

Cancer Family History ASCO genetics hereditary

Every day, oncology clinicians are asked to do more with less.  What I mean by this is, reimbursement for many services has gone down or is inadequate, and physicians are asked to do more during a patient visit with less time available. Yesterday I had the wonderful opportunity to present to a local oncology department in … Continue reading Doing More with Less: Capturing Adequate Cancer Family History

New hope in HER-2 Positive Metastatic Breast Cancer

Hope for metastatic breast cancer patients

Last week marked a very exciting moment for anyone with any involvement in breast cancer patient care, including, and especially, for breast cancer patients.  On February 22 2013, the FDA approved Kadcyla, a new treatment for HER-2 positive metastatic breast cancer. Kadcyla was formerly known to many in the cancer world as T-DM1 and has … Continue reading New hope in HER-2 Positive Metastatic Breast Cancer